Mark Bieniarz, MD
Interventional Cardiology · Albuquerque, NMNPI 1174776868
Payments from drug & device makers
Across 949 payments — averaging $314.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$92K
- Abiomed$89K
- Edwards Lifesciences$72K
- Amgen$21K
- Terumo Medical Corporation$7K
- Merit Medical Systems Inc$4K
- plus $13K from 29 others
Across 2 payments — averaging $103.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$207
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 64 | $91,999 |
| Abiomed | 163 | $88,641 |
| Edwards Lifesciences | 186 | $72,339 |
| Amgen | 67 | $21,289 |
| Terumo Medical Corporation | 6 | $6,892 |
| Merit Medical Systems Inc | 2 | $4,400 |
| Abbott | 103 | $2,993 |
| Ancora Heart, Inc. | 17 | $2,647 |
| Boston Scientific | 100 | $2,080 |
| Philips North America LLC | 37 | $956 |
| Medtronic(2 entities) | 31 | $889 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $575 |
| W. L. Gore & Associates, Inc. | 16 | $476 |
| Johnson & Johnson | 22 | $423 |
| E.r. Squibb & Sons, L.L.C. | 20 | $372 |
| AstraZeneca | 22 | $343 |
| Cardiovascular Systems Inc. | 15 | $266 |
| Livanova USA, Inc. | 3 | $231 |
| Pfizer | 10 | $204 |
| Baxter Healthcare | 4 | $139 |
| Shockwave Medical, Inc | 7 | $108 |
| Biosense Webster, Inc. | 4 | $78 |
| Inspire Medical Systems, Inc. | 2 | $73 |
| Chiesi USA, Inc. | 4 | $57 |
| Merck | 2 | $39 |
| Boehringer Ingelheim | 2 | $29 |
| Tactile Systems Technology Inc | 2 | $29 |
| Novo Nordisk | 1 | $28 |
| Cordis US CORP. | 1 | $21 |
| Teleflex LLC | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Itamar Medical Inc | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Bayer | 1 | $12 |
How this compares
$298,706 in reported general payments places this provider in the 95th percentile of 25 interventional cardiology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Albuquerque
- James BlankenshipAlbuquerque$782K
- Raymond YauAlbuquerque$215K
- Robert FedericiAlbuquerque$77K
- Geoffrey KunzAlbuquerque$35K
- Sharif HalimAlbuquerque$34K
- Charles KimAlbuquerque$20K
- Harvey WhiteAlbuquerque$3K
- Guilherme MarinAlbuquerque$3K
- John BattyAlbuquerque$82
- Abdul KhanLas Cruces$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.